General Electric (GE) has collaborated with the Defense Advanced Research Projects Agency (DARPA) on a $2.9m research project to develop non-drug treatments for diabetes.
During the three-year research programme, GE Bioelectronic scientists who specialise in bioelectronic medicine will explore new methods to treat diabetes by using electronic devices.
They will work on non-invasive, stimulation technique technology that would reverse or treat diabetes.
